Wipo Igc Negotiations India.

I. WIPO IGC Overview

The WIPO IGC is a specialized committee under the World Intellectual Property Organization (WIPO) focusing on:

Genetic Resources (GRs) – Plants, animals, microorganisms, or their derivatives used in research, biotechnology, and pharmaceuticals.

Traditional Knowledge (TK) – Knowledge, innovations, and practices of indigenous and local communities.

Traditional Cultural Expressions (TCEs) or Folklore – Art, designs, music, rituals, and oral expressions of cultural significance.

Objective of IGC Negotiations

Develop international legal instruments to prevent misappropriation (biopiracy).

Ensure equitable benefit-sharing for indigenous communities.

Create mechanisms to protect TK, TCEs, and GRs from unauthorized commercial exploitation.

Promote national implementation guidelines aligned with the Convention on Biological Diversity (CBD) and Nagoya Protocol.

II. India’s Position in IGC Negotiations

India has been a strong advocate for protecting TK and GRs, emphasizing:

Preventing patenting of traditional knowledge without benefit-sharing.

Recognition of community rights over biological resources.

Disclosure of source/origin in patent applications as mandatory.

Incorporation of sui generis protection for TK (customized protection frameworks outside regular IP).

Key Indian Contributions in IGC

India proposed the creation of TK databases (e.g., Traditional Knowledge Digital Library – TKDL) to prevent wrongful patents abroad.

Advocated mandatory disclosure of origin in patent applications, later incorporated into Patents (Amendment) Rules, 2005.

III. Indian Legal Framework Relevant to IGC Negotiations

1. Patents Act, 1970 (as amended)

Section 3(p): Inventions obtained from biological resources or TK are non-patentable unless benefit-sharing is disclosed.

Rule 12A & 12B: Mandatory disclosure of source/origin in patent applications.

2. Biological Diversity Act, 2002

Regulates access to biological resources and associated knowledge.

Requires prior approval from National Biodiversity Authority (NBA) for commercial use.

Ensures equitable benefit-sharing with local communities.

3. Protection of Traditional Knowledge

Traditional Knowledge Digital Library (TKDL) codifies Indian medicinal knowledge to prevent patenting of prior art abroad.

IV. Indian Case Laws Related to TK, GRs, and Biopiracy

Here are some key cases illustrating India’s enforcement of TK and GR protection, which aligns with WIPO IGC objectives:

1. Neem Patent Case (European Patent Office, 2000–2005)

Background: US and European patents claimed formulations based on Neem extract for fungicidal use.

Action: India challenged patents using TKDL evidence.

Outcome: Patents revoked.

Significance: Demonstrates India’s strategy to use documented TK to prevent misappropriation, aligning with IGC goals.

2. Turmeric Patent Case (US Patent 5,401,504, 1995)

Background: US patent claimed the use of turmeric for wound healing.

Action: India submitted prior art from Ayurvedic texts via TKDL.

Outcome: Patent revoked in 1997.

Significance: Highlighted importance of databases to protect traditional knowledge globally.

3. Basmati Rice Case (RiceTec Inc. v. India, 1997–2001)

Background: US company RiceTec attempted to patent Basmati rice varieties.

Action: India contested, proving existing prior art and geographical origin.

Outcome: Patent narrowed; India secured protection of geographical indication.

Significance: Reinforced rights of indigenous communities and national ownership of GRs.

4. Rosy Periwinkle Case

Background: Alkaloids extracted from Catharanthus roseus used for cancer drugs were patented abroad.

Issue: No benefit-sharing with Indian farmers.

Significance: Triggered India’s Biological Diversity Act, 2002, enforcing prior approval and benefit-sharing.

5. Turmeric and Other Medicinal Plants Enforcement (TKDL Cases 2005–2010)

Background: Multiple patents in Europe and USA claimed Indian medicinal plants.

Action: India challenged using TKDL documentation.

Outcome: Several patents revoked.

Significance: Demonstrates practical impact of TK disclosure and aligns with WIPO IGC’s objectives of preventing misappropriation.

6. Neem and Rosy Periwinkle Commercial Cases

Background: Companies tried to commercialize neem-based and rosy periwinkle-based formulations.

Outcome: Indian courts and NBA denied access without benefit-sharing, reinforcing sovereign and community rights over GRs.

V. India’s Strategy in IGC Negotiations Based on Cases

Mandatory disclosure of origin in patent applications.

Documentation of TK (TKDL) as evidence of prior art.

Advocating international legal instruments to enforce benefit-sharing.

Using case law precedents to demonstrate misappropriation and need for regulation.

VI. Summary Table of Key Cases and Their Impact

CaseYearSubjectOutcomeSignificance
Neem Patent Challenge2000–2005Fungicidal formulationsPatents revokedTK documentation prevents misappropriation
Turmeric Patent1995–1997Wound healing usePatent revokedTKDL effective as prior art
Basmati Rice (RiceTec)1997–2001Rice variety patentPatent narrowedProtects GRs and geographical indications
Rosy Periwinkle1990sAnti-cancer alkaloidsCommercialization challengedLed to Biological Diversity Act, 2002
Various TKDL Enforcement2005–2010Medicinal plants patentsMultiple patents revokedPractical implementation of TK protection
Neem & Rosy Periwinkle commercial cases2000sGR commercializationAccess denied without benefit-sharingSovereign rights enforcement

VII. Key Takeaways

India actively uses TKDL and legal frameworks to prevent misappropriation, aligned with WIPO IGC objectives.

Section 3(p), 12A, 12B, and Biological Diversity Act form the backbone of India’s domestic protection strategy.

Judicial enforcement and international negotiation go hand-in-hand: patents challenged in Europe/USA use Indian prior art evidence.

WIPO IGC negotiations are strengthened by India’s domestic precedents, showing the need for global instruments to protect TK, TCEs, and GRs.

LEAVE A COMMENT